Literature DB >> 23737206

Physiology of endothelin and the kidney.

Donald E Kohan1, Edward W Inscho, Donald Wesson, David M Pollock.   

Abstract

Since its discovery in 1988 as an endothelial cell-derived peptide that exerts the most potent vasoconstriction of any known endogenous compound, endothelin (ET) has emerged as an important regulator of renal physiology and pathophysiology. This review focuses on how the ET system impacts renal function in health; it is apparent that ET regulates multiple aspects of kidney function. These include modulation of glomerular filtration rate and renal blood flow, control of renin release, and regulation of transport of sodium, water, protons, and bicarbonate. These effects are exerted through ET interactions with almost every cell type in the kidney, including mesangial cells, podocytes, endothelium, vascular smooth muscle, every section of the nephron, and renal nerves. In addition, while not the subject of the current review, ET can also indirectly affect renal function through modulation of extrarenal systems, including the vasculature, nervous system, adrenal gland, circulating hormones, and the heart. As will become apparent, these pleiotropic effects of ET are of fundamental physiologic importance in the control of renal function in health. In addition, to help put these effects into perspective, we will also discuss, albeit to a relatively limited extent, how alterations in the ET system can contribute to hypertension and kidney disease.
© 2011 American Physiological Society. Compr Physiol 1:699-729, 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23737206      PMCID: PMC3940435          DOI: 10.1002/cphy.c100039

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  521 in total

1.  Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF.

Authors:  A López-Farré; D Gómez-Garre; F Bernabeu; I Montañés; I Millás; J M López-Novoa
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

2.  Differential effects of endothelin-1 and big endothelin on canine kidneys.

Authors:  S Akabane; H Yoshimi; K Yoshida; Y Kawano; T Ashida; O Kinoshita; Y Matsushima; M Kawamura; M Imanishi; M Kuramochi
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  Endothelin production by human inner medullary collecting duct cells.

Authors:  D E Kohan
Journal:  J Am Soc Nephrol       Date:  1993-04       Impact factor: 10.121

4.  Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule.

Authors:  Bruno A Escalante; John C McGiff; Adebayo O Oyekan
Journal:  Am J Physiol Renal Physiol       Date:  2002-01

5.  The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression.

Authors:  A Inoue; M Yanagisawa; Y Takuwa; Y Mitsui; M Kobayashi; T Masaki
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

6.  Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation.

Authors:  M S Simonson; M J Dunn
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 7.  Kidney CYP450 enzymes: biological actions beyond drug metabolism.

Authors:  X Zhao; J D Imig
Journal:  Curr Drug Metab       Date:  2003-02       Impact factor: 3.731

8.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

Authors:  H Ito; Y Hirata; S Adachi; M Tanaka; M Tsujino; A Koike; A Nogami; F Murumo; M Hiroe
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Endothelin-1 increases rat distal tubule acidification in vivo.

Authors:  D E Wesson; G M Dolson
Journal:  Am J Physiol       Date:  1997-10

10.  Endothelin influences pHi of human platelets through protein kinase C mediated pathways.

Authors:  R M Touyz; R Larivière; E L Schiffrin
Journal:  Thromb Res       Date:  1995-04-01       Impact factor: 3.944

View more
  56 in total

1.  Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.

Authors:  Aurélie Borrull; Bertrand Allard; Anne Wijkhuisen; Amaury Herbet; Patricia Lamourette; Wided Birouk; Denis Leiber; Zahra Tanfin; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud; Philippe Robin
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

2.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

3.  Endothelin receptor A and p66Shc regulate spontaneous Ca2+ oscillations in smooth muscle cells controlling renal arterial spontaneous motion.

Authors:  Oleg Palygin; Bradley S Miller; Yoshinori Nishijima; David X Zhang; Alexander Staruschenko; Andrey Sorokin
Journal:  FASEB J       Date:  2018-10-10       Impact factor: 5.191

Review 4.  Inhibition of ENaC by endothelin-1.

Authors:  Andrey Sorokin; Alexander Staruschenko
Journal:  Vitam Horm       Date:  2015-03-06       Impact factor: 3.421

5.  Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade.

Authors:  Denisha Spires; Bibek Poudel; Corbin A Shields; Alyssa Pennington; Brianca Fizer; Lateia Taylor; Kasi C McPherson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-30

Review 6.  Endothelium-derived ET-1 and the development of renal injury.

Authors:  Carmen De Miguel; David M Pollock; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-20       Impact factor: 3.619

7.  Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.

Authors:  Chunhua Jin; Yejoo Jeon; Daniel T Kleven; Jennifer S Pollock; John J White; David M Pollock
Journal:  J Pharmacol Exp Ther       Date:  2014-09-04       Impact factor: 4.030

8.  Natriuretic response to renal medullary endothelin B receptor activation is impaired in Dahl-salt sensitive rats on a high-fat diet.

Authors:  W Kittikulsuth; K A Hyndman; J S Pollock; D M Pollock
Journal:  Physiol Res       Date:  2018-06-27       Impact factor: 1.881

9.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

Review 10.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.